Back

Understanding the prevalence and burden of cardiac amyloidosis

20 May 2023 (12:30 - 12:35)
Organised by: Logo
Congress Presentation Part of: Heart failure and ATTR-CM: recognizing an underdiagnosed condition Myocardial Disease Open Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Professor Ales Linhart

First Faculty of Medicine and General Teaching Hospital, Prague (Czechia)

4 More presentations in this session

Presentation thumbnail
Expert perspectives on red flags for ATTR-CM: a practical approach
Professor S. Perlini (Pavia, IT)
Slides
Presentation thumbnail
Facilitating non-invasive diagnosis of ATTR-CM through specialist collaboration
Doctor R. Bonfiglioli (Bologna, IT)
Slides
Presentation thumbnail
Clinical and real-world evidence for the treatment of ATTR-CM
Doctor P. Garcia-Pavia (Majadahonda, ES)
Slides
Presentation thumbnail
Q&A
Slides

Access the full session

Session thumbnail
Heart failure and ATTR-CM: recognizing an underdiagnosed condition
Video

The Event

Event poster

Heart Failure 2023

20 May 2023 12:30 CET
You may be interested in
thumbnail
Congress Session
Cardiac amyloidosis and heart failure
20 May 2025
thumbnail
Congress Presentation
Burden of transthyretin amyloid cardiomyopathy in treatment-naive patients by heart failure severity: results from a large, non-interventional, real-world study
21 May 2023
thumbnail
Congress Presentation
Evolving the understanding of TTR's role in health and disease​
31 August 2025
thumbnail
Congress Presentation
Cardiac amyloidosis awareness comparison between HF-cardiologists, non-HF-cardiologists and other specialties around the world: insights from international survey
11 May 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources